Between 2018 - 2022, 12 of the 19 most common cancers in men showed decreases in mortality: prostate, liver and intrahepatic bile duct, esophagus, melanoma of the skin, kidney and renal pelvis, urinary bladder, colon and rectum, leukemia, myeloma, stomach, non-Hodgkin lymphoma, and lung and bronchus. Out of these 12, the death rate from lung and bronchus cancer fell the fastest, dropping by an average of 4.5% each year from 2018 – 2022.
Death rates increased for cancers of the pancreas, bones and joints, oral cavity and pharynx, and non-melanoma skin cancer during this period.
Between 2018 - 2022, 14 of the 20 most common cancers in women showed decreases in mortality: brain and other nervous system, cervix, soft tissue including heart, urinary bladder, kidney and renal pelvis, breast, stomach, leukemia, colon and rectum, myeloma, gallbladder, non-Hodgkin lymphoma, ovary, and lung and bronchus. Like the trends seen among men, the death rate from lung and bronchus cancer among women fell the fastest, with an average annual decrease of 3.4% from 2018 - 2022.
